November 14 is a day of great importance for Ypsomed. Today is World Diabetes Day as well as National Future Day in Switzerland, where our headquarters are located. Today, we have the opportunity to draw attention to diabetes and to equality.
Several customers have recently launched their autoinjectors based on our YpsoMate platform product technology on the market. Customers value the fast product customisation as well as the individual design possibilities. End users appreciate its user-friendliness.
For a globally operating medical devices company, there are many difficulties, barriers and insecurities in the worldwide supply of medical products, which pose challenges for logistics. Challenges that our logistics department masters on a daily basis.
Digitisation opens the door for new products and new possibilities in the diabetes therapy management. Due to digitisation, patients are gaining knowledge and independence and therefore their demands increase. As a result, the patient-doctor relationship is undergoing change.
The number of Type 1 diabetics using old insulin pumps without secure communication interfaces to build their own “Closed Loop” system is growing steadily. The so-called “loopers” are thus sending a clear signal to manufacturers and showing what is in demand for insulin pump therapy.